GUSHENGTANG (02273) intends to acquire 100% equity and related interests of Dazhongtang subsidiary.

GUSHENGTANG (02273) announced that on November 16, 2025, its subsidiary Gushengtang Singapore TCM Healthcare Technologies Holdings Private Limited (Gushengtang Singapore) entered into a share transfer agreement with DA ZHONG TANG PTE. LTD. (Seller). Gushengtang Singapore agreed to acquire, while the Seller agreed to sell, 100% of the shares and related interests of Da Zhong Tang (the Acquisition). Upon completion of the Acquisition, Da Zhong Tang will become a subsidiary of the Company, and the financial performance of Da Zhong Tang will be consolidated into the Group's financial statements. The Acquisition aligns with the Group's expansion strategy of expanding its offline medical institution network through acquisitions, on the condition that the Company believes the Acquisition will increase our market share in Singapore and create synergies between Da Zhong Tang and the Group's other offline medical institutions and online medical platforms. The price of the Acquisition was determined through fair negotiations between Gushengtang Singapore and the Seller, taking into consideration Da Zhong Tang's historical performance, qualifications, resources, and prospects. The directors believe that the price represents a fair and reasonable valuation of Da Zhong Tang. The price will be funded by the net proceeds from the Company's share placement, idle funds of the Group, and Gushengtang Singapore's own funds.